Quant Mid Cap Fund
Direct · GrowthAI Summary
Quant Mid Cap Fund has delivered strong long-term SIP returns, with a 10Y XIRR of 22.22% and 7Y XIRR of 21.97%, outperforming the category averages of 19.41% and 19.29% respectively. However, recent performance has lagged, with the 1Y XIRR of 20.47% trailing the category average of 21.6% and negative alpha of -2.41% versus the NIFTY Midcap 150 over the same period. Over longer horizons the fund has beaten the benchmark, with a 7Y alpha of 4.82% and 10Y alpha of 3.01%.
The fund exhibits a defensive risk profile relative to its benchmark, with beta declining from 0.90 over 3Y to 0.73 over 15Y and consistently lower downside capture than upside capture (e.g., 82.61% downside vs 86.49% upside over 10Y). It has experienced 7 drawdown events greater than 10%, which is notable for a mid-cap fund, though the current maximum drawdown is minimal at -0.33% with a 133-day recovery. Calmar ratios remain stable in the 0.53-0.59 range across horizons, indicating consistent risk-adjusted returns.
The portfolio is highly concentrated with only 22 total holdings, and the top three positions — Aurobindo Pharma (9.95%), Lloyds Metals and Energy (9.27%), and Tata Communications (8.50%) — account for roughly 27.7% of NAV. Sector exposure is led by Telecom Services (14.4%) and Pharmaceuticals (12.0%), with meaningful allocations to Minerals & Mining and Construction. This concentrated, high-conviction approach increases single-stock and sector-specific risk compared to more diversified mid-cap peers.
The fund has outperformed the category average SIP XIRR over 5Y (20.59% vs 19.38%), 7Y (21.97% vs 19.29%), 10Y (22.22% vs 19.41%), and 12Y (19.80% vs 18.82%) horizons, demonstrating strong long-term consistency. Its only category lags are over 1Y (20.47% vs 21.6%) and 3Y (19.32% vs 19.93%), reflecting recent underperformance. Calendar year returns show strong upside years such as 52.05% in 2021 and 34.75% in 2023, alongside modest losses in 2016, 2018, 2019, and 2025.
This fund suits investors with a high risk tolerance and an investment horizon of at least 5-7 years, as its outperformance versus both benchmark and category emerges primarily over longer periods. Its concentrated portfolio and mid-cap exposure make it prone to meaningful drawdowns, so investors should be prepared for interim volatility. It can serve as a satellite mid-cap allocation within a diversified portfolio rather than a core holding.
- Strong long-term SIP performance with 10Y XIRR of 22.22% and 7Y XIRR of 21.97%, both well above category averages
- Consistent positive alpha over longer horizons, including 4.82% over 7Y and 3.01% over 10Y versus the NIFTY Midcap 150
- Favorable downside protection with downside capture below upside capture across most periods (e.g., 76.42% vs 80.13% over 12Y)
- Recent underperformance with negative alpha of -2.41% over 1Y and -3.06% over 3Y versus the benchmark
- High portfolio concentration with only 22 holdings and the top three stocks comprising roughly 27.7% of NAV
Generated on 06-09-2026, 7:54 PM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.72 L | 20.5% | -48.2% | 109.9% |
| 3 Years | ₹36.00 L | ₹42.96 L | 19.3% | -19.4% | 53.1% |
| 5 Years | ₹60.00 L | ₹99.16 L | 20.6% | -8.9% | 44.5% |
| 7 Years | ₹84.00 L | ₹1.89 Cr | 22.0% | -3.2% | 35.8% |
| 10 Years | ₹1.20 Cr | ₹3.71 Cr | 22.2% | 17.7% | 27.8% |
| 12 Years | ₹1.44 Cr | ₹5.10 Cr | 19.8% | 17.1% | 22.7% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY MIDCAP 150 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 20.5% | 22.1% | 21.6% | -1.6% |
| 3 Years | 19.3% | 17.3% | 19.9% | +2.0% |
| 5 Years | 20.6% | 16.5% | 19.4% | +4.1% |
| 7 Years | 22.0% | 16.7% | 19.3% | +5.2% |
| 10 Years | 22.2% | 16.6% | 19.4% | +5.6% |
| 12 Years | 19.8% | 16.3% | 18.8% | +3.5% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 19.8% | 13.1% | -29.5% | 121.3% | 0.51 | 2.03 | 78% | — | — |
| 3 Years | 19.4% | 15.1% | -5.5% | 50.0% | 1.06 | 11.12 | 99% | — | — |
| 5 Years | 19.6% | 19.9% | -2.2% | 41.5% | 1.32 | 13.69 | 99% | — | — |
| 10 Years | 18.8% | 18.3% | 15.8% | 22.5% | 7.33 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY MIDCAP 150
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | -2.41 | 0.77 | 79.4% | 81.6% | 6.7% | 9.9% |
| 3 Years | -3.06 | 0.90 | 88.1% | 89.7% | 13.9% | 18.1% |
| 5 Years | +0.57 | 0.95 | 95.2% | 94.0% | 17.5% | 17.5% |
| 7 Years | +4.82 | 0.92 | 93.3% | 88.6% | 25.6% | 22.1% |
| 10 Years | +3.01 | 0.86 | 86.5% | 82.6% | 18.3% | 16.8% |
| 12 Years | +2.27 | 0.80 | 80.1% | 76.4% | 17.1% | 16.9% |
| 15 Years | +2.10 | 0.73 | 72.9% | 68.3% | 15.1% | 15.3% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Aurobindo Pharma Limited | 9.95% |
| 2 | Lloyds Metals And Energy Limited | 9.27% |
| 3 | Tata Communications Limited | 8.50% |
| 4 | IRB Infrastructure Developers Limited | 6.16% |
| 5 | Indus Towers Limited | 5.95% |
| 6 | Bharat Heavy Electricals Ltd | 4.65% |
| 7 | ICICI Bank Limited | 4.63% |
| 8 | Nippon Life India Asset Management Ltd | 4.54% |
| 9 | LG Electronics India Limited | 3.92% |
| 10 | Linde India Ltd. | 3.57% |